Schley, Gunnar ; Klanke, Bernd ; Kalucka, Joanna 
; Schatz, Valentin ; Daniel, Christoph ; Mayer, Marleen ; Goppelt-Struebe, Margarete ; Herrmann, Martin ; Thorsteinsdottir, Margret ; Palsson, Runolfur ; Beneke, Angelika ; Katschinski, Dörthe M. ; Burzlaff, Nicolai ; Eckardt, Kai-Uwe ; Weidemann, Alexander ; Jantsch, Jonathan ; Willam, Carsten
; Schatz, Valentin ; Daniel, Christoph ; Mayer, Marleen ; Goppelt-Struebe, Margarete ; Herrmann, Martin ; Thorsteinsdottir, Margret ; Palsson, Runolfur ; Beneke, Angelika ; Katschinski, Dörthe M. ; Burzlaff, Nicolai ; Eckardt, Kai-Uwe ; Weidemann, Alexander ; Jantsch, Jonathan ; Willam, Carsten 
Zusammenfassung
Prolyl hydroxylase domain enzyme inhibitors (PHDIs) stabilize hypoxia-inducible factors (HIFs), and are protective in models of acute ischemic and inflammatory kidney disease. Whether PHDIs also confer protection in chronic inflammatory kidney disease models remains unknown. Here we investigated long-term effects of PHDI treatment in adenine-induced nephropathy as a model for chronic ...
Nur für Besitzer und Autoren: Kontrollseite des Eintrags
Altmetric